Europska Unija - hrvatski - EMA (European Medicines Agency)

merck sharp dohme ltd - Боцепревир - hepatitis c, kronični - antivirusni lijekovi za sustavnu uporabu - victrelis je indiciran za liječenje kroničnog hepatitisa c (chc) genotipa 1 infekcije, u kombinaciji s peginterferonom alfa i ribavirinom u odraslih bolesnika s kompenziranom bolešću jetre koji prethodno nisu bili liječeni ili nisu odgovorili na prethodnu terapiju.

Europska Unija - hrvatski - EMA (European Medicines Agency)

astrazeneca ab - tixagevimab, cilgavimab - covid-19 virus infection - prevention of covid-19.

Europska Unija - hrvatski - EMA (European Medicines Agency)

janssen-cilag international nv - guselkumab - psorijaza - imunosupresivi - plaque psoriasis tremfya is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritis tremfya, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adult patients who have had an inadequate response or who have been intolerant to a prior disease-modifying antirheumatic drug (dmard) therapy (see section 5.

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

biomedica dijagnostika d.o.o., zagreb - in vitro dijagnostika, identifikacija kodiranih alela s dnk uzorka

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

biomedica dijagnostika d.o.o., zagreb - in vitro dijagnostika, dna pločice za tipizaciju

Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

inpharm co. d.o.o. banja luka - guselkumab - rastvor za injekciju u napunjenom špricu - 100 mg/1 ml - jedan napunjen injekcioni špric sadrži: 100 mg guselkumaba u 1 ml rastvora

Europska Unija - hrvatski - EMA (European Medicines Agency)

gilead sciences ireland uc - remdesivir - covid-19 virus infection - veklury is indicated for the treatment of coronavirus disease 2019 (covid 19) in:adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment)adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.

Europska Unija - hrvatski - EMA (European Medicines Agency)

glaxosmithkline trading services limited - sotrovimab - covid-19 virus infection - imuni serumi i homologna, - xevudy is indicated for the treatment of adults and adolescents (aged 12 years and over and weighing at least 40 kg) with coronavirus disease 2019 (covid-19) who do not require oxygen supplementation and who are at increased risk of progressing to severe covid-19.

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

alkaloid d.o.o., slavonska avenija 6 a, zagreb, hrvatska - lamotrigin - tableta - 100 mg - urbroj: jedna tableta sadrži 100 mg lamotrigina

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

alkaloid d.o.o., slavonska avenija 6 a, zagreb, hrvatska - lamotrigin - tableta - 200 mg - urbroj: jedna tableta sadrži 200 mg lamotrigina